Breaking News Instant updates and real-time market news.

2022-01-18 17:34:24 UCBI United Community Banks $38.50 / -0.59 (-1.51%) 17:34 01/18/22 01/18 17:34 01/18/22 17:34	United Community Banks reports Q4 operating EPS 64c, consensus 64c Reports Q4 revenue $175.4M, consensus $178.67M. CEO Lynn Harton stated, "We are very pleased by United's performance this quarter and in 2021. In the quarter, both loan and deposit growth were strong and noninterest income benefited from strong, but seasonally lower, mortgage production and a great SBA quarter. On the strategic front, we completed the acquisition of Aquesta Financial Holdings, Inc. and Aquesta Bank on October 1, boosting our Charlotte presence and adding the Wilmington, North Carolina market, both of which are growth markets that fit well with our footprint and culture. We also completed the operational conversion of Aquesta in mid-November, bringing the United brand to these great markets. We are proud that this outstanding team of bankers has joined us and we believe that they are a great fit for United. Finally, while not included in the quarterly results, on January 1 we completed the acquisition of Reliant Bancorp, expanding our Tennessee presence into the fast-growing Nashville MSA with a very high performance organization."	22 Mar

2022-01-18 17:34:24

UCBI

United Community Banks

$38.50 / -0.59 (-1.51%)

17:34

01/18/22

01/18

17:34

01/18/22

17:34

United Community Banks reports Q4 operating EPS 64c, consensus 64c

Reports Q4 revenue $175.4M, consensus $178.67M. CEO Lynn Harton stated, "We are very pleased by United's performance this quarter and in 2021. In the quarter, both loan and deposit growth were strong and noninterest income benefited from strong, but seasonally lower, mortgage production and a great SBA quarter. On the strategic front, we completed the acquisition of Aquesta Financial Holdings, Inc. and Aquesta Bank on October 1, boosting our Charlotte presence and adding the Wilmington, North Carolina market, both of which are growth markets that fit well with our footprint and culture. We also completed the operational conversion of Aquesta in mid-November, bringing the United brand to these great markets. We are proud that this outstanding team of bankers has joined us and we believe that they are a great fit for United. Finally, while not included in the quarterly results, on January 1 we completed the acquisition of Reliant Bancorp, expanding our Tennessee presence into the fast-growing Nashville MSA with a very high performance organization."

22
Mar

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Asur reports June traffic up 23.1% y/y, up 16.9% y/y from 2019 » 17:54 07/06/22 07/06 17:54 07/06/22 17:54 ASR Asur $194.30 / +2.5 (+1.30%) Grupo Aeroportuario del… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ASR Asur $194.30 / +2.5 (+1.30%) 06/06/22 Asur reports May passenger traffic 5.5M, up 20.4% from May 2019 05/05/22 Asur reports total passenger traffic for April 2022 03/07/22 Asur reports February 2022 passenger traffic up 7% from February 2019 02/08/22 Asur reports January traffic up 3.3% from 2019 level ASR Asur $194.30 / +2.5 (+1.30%) 02/08/22 Bradesco BBI Asur downgraded to Neutral from Outperform at Bradesco BBI 11/30/21 Goldman Sachs Asur upgraded to Neutral from Sell at Goldman Sachs 11/30/21 Goldman Sachs OMA upgraded to Buy from Neutral at Goldman Sachs 10/13/21 Citi Asur price target raised to $218 from $191 at Citi
Hot Stocks	Volaris reports June traffic results up 11% year-over-year » 17:34 07/06/22 07/06 17:34 07/06/22 17:34 VLRS Volaris $9.67 / -0.105 (-1.07%) Volaris reports June 2022… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VLRS Volaris $9.67 / -0.105 (-1.07%) 06/02/22 Volaris reports preliminary May traffic up 12.3% 05/04/22 Volaris reports preliminary April traffic results 04/06/22 Volaris reports March preliminary ASMs up 61.2%, RPMs up 60.4% YoY 03/03/22 Volaris reports February demand up 80.8%, capacity up 62.0% VLRS Volaris $9.67 / -0.105 (-1.07%) 06:28 Today Barclays Volaris price target lowered to $16 from $27 at Barclays 06/27/22 Evercore ISI Volaris price target lowered to $20 from $30 at Evercore ISI 06/06/22 JPMorgan Volaris initiated with an Overweight at JPMorgan 02/23/22 Barclays Volaris price target raised to $27 from $25 at Barclays VLRS Volaris $9.67 / -0.105 (-1.07%) 02/24/22 Volaris sees FY22 operating revenue $2.6B-$2.8B, consensus $2.43B 02/24/22 Volaris reports Q4 EBITDAR MXN5.16B, up 45% 06 Aug 07/22/22 Volaris - VLRS
Hot Stocks	General Dynamics awarded $145.47M Defense Logistics Agency contract » 17:19 07/06/22 07/06 17:19 07/06/22 17:19 GD General Dynamics $219.52 / +5.235 (+2.44%) General Dynamics has been… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly GD General Dynamics $219.52 / +5.235 (+2.44%) 06/29/22 General Dynamics awarded $320.33M Army contract modification 06/29/22 GD NASSCO awarded $600M for U.S. Navy contract modifications 06/29/22 General Dynamics Land Systems announces LRIP award valued at $1.14B 05/26/22 General Dynamics awarded $324.52M Space Development Agency contract GD General Dynamics $219.52 / +5.235 (+2.44%) 04/28/22 Susquehanna General Dynamics price target raised to $285 from $280 at Susquehanna 03/29/22 Jefferies Northrop among biggest beneficiaries of DoD budget request, says Jefferies 03/07/22 Wells Fargo General Dynamics price target raised to $282 from $235 at Wells Fargo 02/04/22 Morgan Stanley Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook GD General Dynamics $219.52 / +5.235 (+2.44%) 04/27/22 General Dynamics sees Q2 EPS 10c above Q1 level, consensus $2.86 04/27/22 General Dynamics reports Q1 EPS $2.61, consensus $2.51 04/26/22 Notable companies reporting before tomorrow's open 04/26/22 Notable companies reporting before tomorrow's open GD General Dynamics $219.52 / +5.235 (+2.44%) 04/19/22 Lockheed Martin in talks with Pentagon on weapons to Ukraine, WSJ reports 04/13/22 Defense contractors to meet with Pentagon to discuss Ukraine aid, FT reports 04/05/22 U.S., U.K. and Australia to co-operate on hypersonic weapons, FT says GD General Dynamics $219.52 / +5.235 (+2.44%) 04/27/22 Fly Intel: Pre-market Movers 02/28/22 Fly Intel: Pre-market Movers 02/11/22 Wall Street in Fives - Must Read Lists for Friday 01/26/22 Wall Street in Fives - Must Read Lists for Wednesday
Hot Stocks	DiaMedica Therapeutics down 38% to $1.25 after placing DM199 on clinical hold 17:13 07/06/22 07/06 17:13 07/06/22 17:13 DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 17:00 Today DiaMedica Therapeutics trading resumes 16:49 Today DiaMedica Therapeutics to resume trading at 17:00ET 16:34 Today DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial 16:28 Today DiaMedica Therapeutics trading halted, news pending DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 09/27/21 Roth Capital DiaMedica price target lowered to $24 from $32 at Roth Capital DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 03/14/22 DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c) DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 05/04/22 Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls 08/08/22 Biotechnology Conference
Hot Stocks	Shore Bancshares authorizes up to $5M stock buyback » 17:09 07/06/22 07/06 17:09 07/06/22 17:09 SHBI Shore Bancshares $18.53 / -0.02 (-0.11%) Shore Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings SHBI Shore Bancshares $18.53 / -0.02 (-0.11%) 11/04/21 Piper Sandler Shore Bancshares upgraded to Overweight from Neutral at Piper Sandler SHBI Shore Bancshares $18.53 / -0.02 (-0.11%) 02/14/22 Shore Bancshares reports Q4 GAAP EPS 16c , consensus 37c
Syndicate	Oil States files to sell 1.9M shares of common stock for holders 17:08 07/06/22 07/06 17:08 07/06/22 17:08 OIS Oil States $4.68 / -0.23 (-4.68%) ShowHide Related Items >><< Company News Street Research Earnings OIS Oil States $4.68 / -0.23 (-4.68%) 07/05/22 Oil States names Philip Moses as COO 03/07/22 Oil States rises 26.5% OIS Oil States $4.68 / -0.23 (-4.68%) 04/18/22 Piper Sandler Oil States price target raised to $10 from $8 at Piper Sandler 03/07/22 Piper Sandler Oil States upgraded to Overweight with 45% upside at Piper Sandler 03/04/22 Piper Sandler Oil States upgraded to Overweight from Neutral at Piper Sandler OIS Oil States $4.68 / -0.23 (-4.68%) 04/28/22 Oil States reports Q1 EPS (16c), consensus (13c) 02/16/22 Oil States reports Q4 EPS (14c), consensus (13c)
Hot Stocks	China Green removed from NYSE late filers list following quarterly report » 17:02 07/06/22 07/06 17:02 07/06/22 17:02 CGA China Green $5.26 / -0.885 (-14.41%) China Green announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News CGA China Green $5.26 / -0.885 (-14.41%) 05/27/22 China Green discloses NYSE notice regarding late 10-Q filing 05/25/22 China Green falls -7.6% 05/25/22 China Green falls -8.0% 05/25/22 China Green falls -8.0%
Hot Stocks	Blackstone announces $400M investment in Xpansiv » 17:01 07/06/22 07/06 17:01 07/06/22 17:01 BX Blackstone $93.96 / -0.005 (-0.01%) Blackstone… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BX Blackstone $93.96 / -0.005 (-0.01%) 07/01/22 Blackstone, RiseBoro enter agreement to resructure partnership 06/30/22 Skillz appoints Jason Roswig as CFO 06/09/22 Preferred Apartment: Proxy firms urge holders to vote 'FOR" BREIT acquisition 05/19/22 Blackstone REIT completes $3.7B acquisition of Resource REIT BX Blackstone $93.96 / -0.005 (-0.01%) 05/19/22 Deutsche Bank Blackstone price target lowered to $180 from $182 at Deutsche Bank 04/27/22 Argus American Campus downgraded to Hold from Buy at Argus 04/22/22 BMO Capital Blackstone price target raised to $142 from $124 at BMO Capital 04/22/22 Deutsche Bank Blackstone price target lowered to $182 from $186 at Deutsche Bank BX Blackstone $93.96 / -0.005 (-0.01%) 01/27/22 Blackstone reports Q4 distributable EPS $1.71, consensus $1.37 01/26/22 Notable companies reporting before tomorrow's open 01/26/22 Notable companies reporting before tomorrow's open 08 Dec BX Blackstone $93.96 / -0.005 (-0.01%) 16:15 Today Blackstone to invest $400M in trading platform Xpansiv, WSJ reports 07/05/22 Apollo, Blackstone seek buyers for Ridgeback Resources, Reuters reports 06/22/22 Toshiba bidders could offer up to $51.41 per share in buyout, Reuters reports 06/22/22 Blackstone's Crown Resorts permitted to open Sydney casino, WSJ reports BX Blackstone $93.96 / -0.005 (-0.01%) 07/05/22 What You Missed On Wall Street On Tuesday 05/26/22 What You Missed On Wall Street On Thursday 05/26/22 What You Missed On Wall Street This Morning 05/11/22 What You Missed On Wall Street On Wednesday 07/21/22 Blackstone - BX 09/29/22 Blackstone BX Blackstone $93.96 / -0.005 (-0.01%) 06/28/22 Blackstone put volume heavy and directionally bearish 06/16/22 Blackstone put volume heavy and directionally bearish 06/01/22 Blackstone put volume heavy and directionally bearish 05/24/22 Blackstone put volume heavy and directionally bearish
Hot Stocks	DiaMedica Therapeutics trading resumes 17:00 07/06/22 07/06 17:00 07/06/22 17:00 DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 16:49 Today DiaMedica Therapeutics to resume trading at 17:00ET 16:34 Today DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial 16:28 Today DiaMedica Therapeutics trading halted, news pending 05/04/22 DiaMedica CEO expects final data will be consistent with interim data from REDUX DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 09/27/21 Roth Capital DiaMedica price target lowered to $24 from $32 at Roth Capital DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 03/14/22 DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c) DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 05/04/22 Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls 08/08/22 Biotechnology Conference
Syndicate	Duckhorn Portfolio offers to sell 5M shares of common stock for holder » 16:56 07/06/22 07/06 16:56 07/06/22 16:56 NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) The Duckhorn Portfolio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/03/22 Duckhorn Portfolio rises 8.4% 06/03/22 Duckhorn Portfolio rises 6.4% NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/06/22 Barclays Duckhorn Portfolio price target raised to $21 from $20 at Barclays 03/28/22 RBC Capital Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital 03/10/22 Barclays Duckhorn Portfolio price target lowered to $19 from $22 at Barclays 12/17/21 JPMorgan JPMorgan announces top 2022 stock picks in beverages, personal care NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/02/22 Duckhorn Portfolio raises FY22 EPS view to 59c-62c from 55c-58c 06/02/22 Duckhorn Portfolio reports Q3 adjusted EPS 17c, consensus 13c 03/10/22 Duckhorn Portfolio raises FY22 EPS view to 55c-58c, consensus 58c 03/10/22 Duckhorn Portfolio reports Q2 adjusted EPS 17c, consensus 15c 15 Oct

Hot Stocks	Kilroy Realty announces new onsite solar projects in California » 16:54 07/06/22 07/06 16:54 07/06/22 16:54 KRC Kilroy Realty $53.50 / -1.1 (-2.01%) Kilroy Realty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KRC Kilroy Realty $53.50 / -1.1 (-2.01%) 06/06/22 Kilroy Realty signs leases totaling 190K square feet during Q2 03/10/22 Kilroy Realty announces acquisition of strategic Austin development site KRC Kilroy Realty $53.50 / -1.1 (-2.01%) 06:41 Today Mizuho Kilroy Realty price target lowered to $60 from $77 at Mizuho 07/05/22 RBC Capital Kilroy Realty price target lowered to $68 from $80 at RBC Capital 06/30/22 Jefferies Kilroy Realty price target lowered to $58 from $76 at Jefferies 06/22/22 Credit Suisse Kilroy Realty initiated with an Underperform at Credit Suisse KRC Kilroy Realty $53.50 / -1.1 (-2.01%) 04/27/22 Kilroy Realty sees FY22 FFO $4.44-$4.58, consensus $4.48 04/27/22 Kilroy Realty reports Q1 FFO $1.16, consensus $1.09 01/31/22 Kilroy Realty reports Q4 FFO $1.05, consensus 95c KRC Kilroy Realty $53.50 / -1.1 (-2.01%) 05/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/28/22 Kilroy Realty - KRC
Hot Stocks	DiaMedica Therapeutics to resume trading at 17:00ET 16:49 07/06/22 07/06 16:49 07/06/22 16:49 DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 16:34 Today DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial 16:28 Today DiaMedica Therapeutics trading halted, news pending 05/04/22 DiaMedica CEO expects final data will be consistent with interim data from REDUX 05/04/22 Ongoing trials 'slower' due to COVID, DiaMedica CEO tells The Fly DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 09/27/21 Roth Capital DiaMedica price target lowered to $24 from $32 at Roth Capital DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 03/14/22 DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c) DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 05/04/22 Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls 08/08/22 Biotechnology Conference
Hot Stocks	Energy Services of America announces buyback for up to 1M shares of common stock » 16:46 07/06/22 07/06 16:46 07/06/22 16:46 ESOA Energy Services of America $2.00 / +0.1 (+5.26%) Energy Services of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News ESOA Energy Services of America $2.00 / +0.1 (+5.26%) 06/13/22 Summit State Bank announces Reynolds joined board of directors 03/24/22 Energy Services of America up after listing on Nasdaq Capital Market
Recommendations	Criteo price target lowered to $35 from $40 at Truist » 16:44 07/06/22 07/06 16:44 07/06/22 16:44 CRTO Criteo $22.93 / -0.73 (-3.09%) Truist analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CRTO Criteo $22.93 / -0.73 (-3.09%) 06/16/22 Criteo 'very pleased' with FCA decision to accept commitments offered by Meta 03/03/22 Criteo unable to anticipate closing of IPONWEB deal due to Russian invasion 02/23/22 Criteo partners with Michaels for retail media advertising on Michaels.com 02/16/22 Google announces 'Privacy Sandbox on Android' CRTO Criteo $22.93 / -0.73 (-3.09%) 06/29/22 JPMorgan Criteo price target lowered to $29 from $40 at JPMorgan 06/16/22 Truist France ruling on Meta incremental positive for Criteo, says Truist 05/02/22 Truist Criteo price target lowered to $40 from $45 at Truist 03/03/22 Truist Criteo price target lowered to $45 from $50 at Truist CRTO Criteo $22.93 / -0.73 (-3.09%) 05/04/22 Criteo lowers FY22 revenue ex-TAC growth view to 8%-10% at constant currency 05/04/22 Criteo sees Q2 revenue ex-TAC $220M-$224M, consensus $234.21M 05/04/22 Criteo reports Q1 adjusted EPS 53c, consensus 45c 02/09/22 Criteo sees Q1 revenue ex-TAC $216M-$220M, consensus $233.41M CRTO Criteo $22.93 / -0.73 (-3.09%) 04/26/22 What Wall Street is saying about Alphabet ahead of earnings 02/16/22 What You Missed On Wall Street On Wednesday 02/16/22 What You Missed On Wall Street This Morning
General News	API crude inventories for week of July 1 » 16:40 07/06/22 07/06 16:40 07/06/22 16:40 USO United States Oil Fund $73.62 / -1.17 (-1.56%) API reports that crude… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options USO United States Oil Fund $73.62 / -1.17 (-1.56%) 06/14/22 Freeport LNG issues update on incident at liquefaction plant on June 8 USO United States Oil Fund $73.62 / -1.17 (-1.56%) 03/09/22 UAE to encourage OPEC to raise oil production, FT reports 03/04/22 Biden administration mulls ban on U.S. imports of Russian crude, Bloomberg says USO United States Oil Fund $73.62 / -1.17 (-1.56%) 03/04/22 What You Missed On Wall Street On Friday 02/02/22 Wall Street in Fives - Must Read Lists for Wednesday USO United States Oil Fund $73.62 / -1.17 (-1.56%) 07/05/22 Unusually active option classes on open July 5th 06/22/22 Unusually active option classes on open June 22nd
Hot Stocks	Crescent Point Energy raises quarterly dividend to 8c per share from 5c » 16:38 07/06/22 07/06 16:38 07/06/22 16:38 CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) The Company's Board… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 05/12/22 Crescent Point now expects to generate $1.2B-$1.4B of excess cash flow in 2022 05/12/22 Crescent Point Energy raises quarterly dividend by over 40% to 6.5c per share 03/04/22 Crescent Point Energy receives TSX approval for normal course issuer bid CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 06/30/22 Stifel Crescent Point Energy price target raised to C$17 from C$15.50 at Stifel 06/16/22 National Bank Crescent Point Energy price target raised to C$23 from C$20 at National Bank 06/15/22 CIBC Crescent Point Energy price target raised to C$16 from C$13.50 at CIBC 06/08/22 Scotiabank Crescent Point Energy upgraded to Outperform from Sector Perform at Scotiabank CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 05/12/22 Crescent Point Energy reports Q1 adjusted EPS 41c, consensus 25c CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 02/07/22 Documents show Crescent Point looking to sell some oil, gas assets, Reuters says CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CPG Crescent Point Energy $6.39 / -0.385 (-5.68%) 15:25 Today Crescent Point Energy call volume above normal and directionally bullish 06/17/22 Crescent Point Energy call volume above normal and directionally bullish 06/14/22 Crescent Point Energy call volume above normal and directionally bullish
Hot Stocks	Reservoir Media 'commends' U.S. Copyright Royalty Board phonorecords ruling » 16:37 07/06/22 07/06 16:37 07/06/22 16:37 RSVR Reservoir Media $6.48 / -0.02 (-0.31%) Reservoir Media, Inc.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RSVR Reservoir Media $6.48 / -0.02 (-0.31%) 07/05/22 Reservoir Media added to Russell 2000 Index 05/10/22 Reservoir Media announces deal with Mohamed Ramadan, purchase of 100COPIES 03/29/22 Reservoir Media announces deal for catalog of Larry Kusik 03/22/22 Reservoir Media acquires rights to the catalog of composer Henry Jackman RSVR Reservoir Media $6.48 / -0.02 (-0.31%) 08/23/21 Craig-Hallum Craig-Hallum bullish on Reservoir Media, initiates with a Buy 08/23/21 Craig-Hallum Reservoir Media initiated with a Buy at Craig-Hallum 08/23/21 Roth Capital Reservoir Media initiated with a Buy at Roth Capital RSVR Reservoir Media $6.48 / -0.02 (-0.31%) 06/21/22 Reservoir Media sees 2023 revenue $116M-$121M, consensus $118.93M 06/21/22 Reservoir Media reports Q4 EPS 14c, consensus 9c 02/08/22 Reservoir Media raises FY22 revenue view to $103M-$105M from $100M-$104M 02/08/22 Reservoir Media reports Q3 EPS 3c, three estimates 3c RSVR Reservoir Media $6.48 / -0.02 (-0.31%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 03/14/22 Fly Insider: Ball Corp, Datadog among week's notable insider trades 08/15/22 Reservoir Media Inc RSVR Reservoir Media $6.48 / -0.02 (-0.31%) 06/23/22 Fourteen new option listings and one option delisting on June 23rd
Periodicals	Apple plans for larger Apple Watch geared towards extreme sports, Bloomberg says » 16:36 07/06/22 07/06 16:36 07/06/22 16:36 AAPL Apple $142.96 / +1.365 (+0.96%) Apple has plans for its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $142.96 / +1.365 (+0.96%) 07/05/22 EU regulators adopt new rules to monitor 'Tech Giants' 07/04/22 Fly Intel: Top five weekend stock stories 06/30/22 Apple's former director of corporate law admits to insider trading 06/30/22 Comcast's Xfinity Stream app launches on Apple TV 4K, Apple TV HD AAPL Apple $142.96 / +1.365 (+0.96%) 07/05/22 Morgan Stanley Apple App Store revenue grew 5% in June quarter, says Morgan Stanley 07/01/22 JPMorgan Apple near-term estimates 'resilient' despite concerns, says JPMorgan 06/30/22 Tigress Financial Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares 06/30/22 Morgan Stanley Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter AAPL Apple $142.96 / +1.365 (+0.96%) 04/28/22 Apple says y/y Q3 revenue growth to be impacted by COVID 04/28/22 Apple reports Q2 EPS $1.52, consensus $1.43 04/28/22 Notable companies reporting after market close 02/27/22 Berkshire operating earnings surge, Buffett repurchases record $27B in stock AAPL Apple $142.96 / +1.365 (+0.96%) 16:04 Today Apple plans rugged sports watch with larger screen for September, Bloomberg says 14:18 Today Apple preparing security feature to combat sophisticated spyware, WSJ says 08:11 Today Kuo: Apple's A16 processor to be exclusive to iPhone 14 Pro, AppleInsider says 06:17 Today Meta Platforms to continue its digital collectibles plan, FT reports AAPL Apple $142.96 / +1.365 (+0.96%) 07/05/22 What You Missed On Wall Street On Tuesday 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 06/28/22 What You Missed On Wall Street On Tuesday 07/28/22 Apple - AAPL AAPL Apple $142.96 / +1.365 (+0.96%) 08:55 Today Notable open interest changes for July 6th 06/30/22 Notable open interest changes for June 30th 06/29/22 Notable open interest changes for June 29th 06/29/22 Apple put buyer realizes 93% same-day gains
Hot Stocks	Veru jumps another 17% after Jefferies predicts FDA authorization » 16:36 07/06/22 07/06 16:36 07/06/22 16:36 VERU Veru $13.03 / +1.52 (+13.21%) Shares of Veru, which… Shares of Veru, which rallied 13% during the trading day to $13.02, jumped another 17% in after-hours trading to $15.39 after Jefferies predicted this morning's COVID-19 data would lead to an Emergency Use Authorization by the FDA in 30 days. Despite recent investor skepticism, the Phase 3 COVID-19 results for sabizabulin published this morning in the New England Journal of Medicine "addressed most concerns," Jefferies analyst Chris Howerton told investors in a research note. He reiterated a Buy rating on the shares with a $55 price target. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VERU Veru $13.03 / +1.52 (+13.21%) 07:41 Today Veru's sabizabulin shows reduction of COVID-19 deaths in published trial 06/07/22 Veru submits EUA application to FDA for sabizabulin 06/06/22 Tang Capital reports 5.2% passive stake in Veru 06/06/22 Veru presents final results from Phase 1b/2 study of sabizabulin VERU Veru $13.03 / +1.52 (+13.21%) 16:31 Today Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies 04/12/22 Oppenheimer Veru price target raised to $36 from $25 at Oppenheimer VERU Veru $13.03 / +1.52 (+13.21%) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) 02/09/22 Veru reports Q1 EPS (8c), consensus (12c) VERU Veru $13.03 / +1.52 (+13.21%) 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $13.03 / +1.52 (+13.21%) 16:12 Today What You Missed On Wall Street On Wednesday 12:01 Today What You Missed On Wall Street This Morning 06/07/22 Fly Intel: Pre-market Movers 06/06/22 Fly Intel: After-Hours Movers VERU Veru $13.03 / +1.52 (+13.21%) 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th 06/03/22 Veru call volume above normal and directionally bullish
Syndicate	Duckhorn Portfolio files automatic mixed securities shelf 16:36 07/06/22 07/06 16:36 07/06/22 16:36 NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/03/22 Duckhorn Portfolio rises 8.4% 06/03/22 Duckhorn Portfolio rises 6.4% NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/06/22 Barclays Duckhorn Portfolio price target raised to $21 from $20 at Barclays 03/28/22 RBC Capital Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital 03/10/22 Barclays Duckhorn Portfolio price target lowered to $19 from $22 at Barclays 12/17/21 JPMorgan JPMorgan announces top 2022 stock picks in beverages, personal care NAPA Duckhorn Portfolio $20.72 / -0.45 (-2.13%) 06/02/22 Duckhorn Portfolio raises FY22 EPS view to 59c-62c from 55c-58c 06/02/22 Duckhorn Portfolio reports Q3 adjusted EPS 17c, consensus 13c 03/10/22 Duckhorn Portfolio raises FY22 EPS view to 55c-58c, consensus 58c 03/10/22 Duckhorn Portfolio reports Q2 adjusted EPS 17c, consensus 15c 15 Oct

Hot Stocks	CytomX Therapeutics trading resumes 16:35 07/06/22 07/06 16:35 07/06/22 16:35 CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) ShowHide Related Items >><< Company News Street Research Earnings Events CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 16:18 Today CytomX Therapeutics to resume trading at 4:35 pm ET 16:16 Today CytomX reports Arm A of praluzatamab ravtansine trial met primary endpoint 16:00 Today CytomX Therapeutics trading halted, news pending 06/16/22 CytomX Therapeutics announces new employment inducement grants CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 06/23/22 BMO Capital CytomX Therapeutics initiated with an Outperform at BMO Capital 05/27/22 Piper Sandler CytomX Therapeutics price target lowered to $10 from $16 at Piper Sandler 01/18/22 Barclays CytomX Therapeutics upgraded to Overweight from Underweight at Barclays 12/22/21 H.C. Wainwright CytomX Therapeutics price target lowered to $11 from $12 at H.C. Wainwright CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 03/01/22 CytomX Therapeutics reports Q4 revenue $19.7M, consensus $24.51M 08/08/22 Biotechnology Conference
Hot Stocks	DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial » 16:34 07/06/22 07/06 16:34 07/06/22 16:34 DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) DiaMedica Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 16:28 Today DiaMedica Therapeutics trading halted, news pending 05/04/22 DiaMedica CEO expects final data will be consistent with interim data from REDUX 05/04/22 Ongoing trials 'slower' due to COVID, DiaMedica CEO tells The Fly 05/04/22 Acute ischemic trial to be complete late 2023, early 2024, DiaMedica CEO says DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 09/27/21 Roth Capital DiaMedica price target lowered to $24 from $32 at Roth Capital DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 03/14/22 DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c) DMAC DiaMedica Therapeutics $2.03 / + (+0.00%) 05/04/22 Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls 08/08/22 Biotechnology Conference
Hot Stocks	Altisource Asset Management appoints Jason Kopcak as CEO » 16:32 07/06/22 07/06 16:32 07/06/22 16:32 AAMC Altisource Asset Management $10.53 / +0.24 (+2.33%) Altisource Asset… Altisource Asset Management announced that the board of directors has appointed Jason Kopcak as the CEO of the company and as a member of the board. Prior to his appointment, Kopcak had been the president and COO of the Company. The board also appointed current director John de Jongh, Jr. as chairman of the board. de Jongh, Jr. had previously been interim chairman of the board. ShowHide Related Items >><< Company News Earnings AAMC Altisource Asset Management $10.53 / +0.24 (+2.33%) 04/27/22 Altisource Asset Management announces stock purchases by directors, officers 03/18/22 Altisource Asset Management creates Aletnerative Lending Group 01/07/22 Altisource announces settlement with Series A Preferred stockholders AAMC Altisource Asset Management $10.53 / +0.24 (+2.33%) 04/22/22 Altisource Asset Management reports Q1 EPS 66c vs. $37.41 last year
Recommendations	Veru data likely portend FDA authorization in 30 days, says Jefferies » 16:31 07/06/22 07/06 16:31 07/06/22 16:31 VERU Veru $13.03 / +1.52 (+13.21%) Despite recent investor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VERU Veru $13.03 / +1.52 (+13.21%) 07:41 Today Veru's sabizabulin shows reduction of COVID-19 deaths in published trial 06/07/22 Veru submits EUA application to FDA for sabizabulin 06/06/22 Tang Capital reports 5.2% passive stake in Veru 06/06/22 Veru presents final results from Phase 1b/2 study of sabizabulin VERU Veru $13.03 / +1.52 (+13.21%) 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies 04/12/22 Oppenheimer Veru price target raised to $36 from $25 at Oppenheimer 04/11/22 Cantor Fitzgerald Veru's Covid data highlights multiple shots on goal, says Cantor Fitzgerald VERU Veru $13.03 / +1.52 (+13.21%) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) 02/09/22 Veru reports Q1 EPS (8c), consensus (12c) VERU Veru $13.03 / +1.52 (+13.21%) 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $13.03 / +1.52 (+13.21%) 16:12 Today What You Missed On Wall Street On Wednesday 12:01 Today What You Missed On Wall Street This Morning 06/07/22 Fly Intel: Pre-market Movers 06/06/22 Fly Intel: After-Hours Movers VERU Veru $13.03 / +1.52 (+13.21%) 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th 06/03/22 Veru call volume above normal and directionally bullish
Hot Stocks	First Bancshares receives regulatory approval for Beach Bancorp merger » 16:31 07/06/22 07/06 16:31 07/06/22 16:31 FBMS First Bancshares $28.69 / -0.42 (-1.44%) The First Bancshares… The First Bancshares announced that it has received all required regulatory approvals for the consummation of its proposed acquisition of Beach Bancorp, parent company of Beach Bank based in Fort Walton Beach, Florida. The proposed acquisition, originally announced on April 26, 2022, is anticipated to become effective on August 1, 2022, subject to the satisfaction of customary closing conditions and the approval of the transaction by BBI's shareholders at the special meeting of BBI shareholders on July 21, 2022. The proposed acquisition will deepen The First's presence in the Florida panhandle, while also providing an entry into the Tampa, Florida market. Upon the completion of the acquisition, Beach Bank will merge with and into The First Bank. ShowHide Related Items >><< Company News Earnings FBMS First Bancshares $28.69 / -0.42 (-1.44%) 04/26/22 First Bancshares raises dividend 6% to 18c 03/09/22 First Bancshares authorizes new share repurchase program 02/08/22 First Bancshares announces renewal of share repurchase plan FBMS First Bancshares $28.69 / -0.42 (-1.44%) 04/26/22 First Bancshares reports Q1 EPS 81c, consensus 72c 04/26/22 First Bancshares to acquire Beach Bancorp 01/26/22 First Bancshares reports Q4 EPS 76c, consensus 75c

Events

Earnings calls, analyst events, roadshows and more

HZNP
Tomorrow at 00:00

PDUFA Date for KRYSTEXXA Government Event
Tomorrow at 00:00

2022 Redburn Autos Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Annual Meeting 2022 of the BRS Conferences

Manchester Metropolitan University, Manchester
Tomorrow at 00:00

3rd Annual Japan New Economy Day Conferences

Virtual Event
Tomorrow at 00:00

16th World Immune Regulation Meeting 2022 Conferences

Davos
Tomorrow at 00:00

2nd Credit Suisse ESG Forum Conferences

Zurich
Tomorrow at 00:00

Solar Energy 20 Future Europe 2022 Conferences

Madrid
EXCOF ...
Tomorrow at 00:00

Small Cap Growth Virtual Investor Conference Conferences

Virtual Conference
Tomorrow at 00:00

Berlin Disruptive Tech Symposium Conferences

Hotel Oderberger, Berlin
Tomorrow at 00:00

Asia Discovery Conference Conferences

London

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	NAPA X NAPA Duckhorn Portfolio Spot Secondary Managers: Credit Suisse $20.73 5M Shares
Thurs	NCPL X NCPL Netcapital Secondary Managers: ThinkEquity $7.65 784K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

United Community Banks reports Q4 operating EPS 64c, consensus 64c

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access